Ono, Koichi
Murakami, Akira
Haishima, Yuji
Funding for this research was provided by:
The Japan Agency for Medical Research and Development. (18mk0102116h0501, 18mk0102116h0501)
Article History
Received: 8 February 2021
Accepted: 20 July 2021
First Online: 5 August 2021
Competing interests
: Koichi ONO & Yuji Haishima: none declared. Akira Murakami: reported receiving grants from Kowa company Ltd, Novartis Pharma K.K., HOYA Corporation, AMO Japan K.K., Otsuka pharmaceutical Co., Ltd, SEED Co., Ltd, SENJU PHARMACEUTICAL Co., Ltd, Pfizer Japan Inc., Alcon Japan Ltd, Santen Pharmaceutical Co., Ltd, and Johnson & Johnson Vison Care; personal fees from Kowa company Ltd, Lion Ltd, Otsuka pharmaceutical Co., Ltd, Alcon Japan Ltd, Santen Pharmaceutical Co., Ltd, and Johnson & Johnson Vison Care outside the submitted work.